Tamoxifen Citrate

Overview

Tamoxifen Citrate is a nonsteroidal antiestrogen that is used in the treatment of breast cancer. It acts as a selective estrogen receptor modulator that blocks estrogen effects in the breast tissue.

API suppliers (12)

Suppliers of Tamoxifen Citrate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• EXCELLA GMBH AND CO KG1 active DMF
• OLON SPAItaly1 active DMF
• EXCELLA GMBH AND CO KG1 active DMF
• OLON SPAItaly1 active DMF
• EXCELLA GMBH AND CO KG1 active DMF
• FUJISAWA DEUTSCHLAND GMBH
• EGIS PHARMACEUTICALS PRIVATE LTD
• FERMION OYFinland
• PCASFrance
• LACHEMA BRNO
• CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
• Asymchem Laboratories (Tianjin) Co., Ltd.China

Chemical identity

IUPAC name

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine

Canonical SMILES

CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3

InChIKey

NKANXQFJJICGDU-QPLCGJKRSA-N

Therapeutic areas